M
Mendel Biotechnology
Plant biotechnology company that develops genetic and chemical solutions for a range of agricultural markets
About Mendel Biotechnology
Founded in 1997, Mendel Biotechnology, Inc. operates as a plant biotechnology company from its base in the San Francisco Bay Area, California. The company was co-founded by Jonathan Jones and Dr. Brian Staskawicz. Staskawicz, a renowned expert in plant biology and a professor at the University of California, Berkeley, has been a member of the board of directors since the company's inception. The firm has focused on researching the control of plant gene regulation, establishing a significant intellectual property portfolio centered on transcription factor-based technologies designed to enhance crop plant traits.
The company's business model revolves around commercializing its proprietary technology through strategic partnerships and licensing agreements with major agricultural companies. Key collaborators have included Monsanto, BP, and Bayer CropScience. The long-term partnership with Monsanto, initiated in 1997, granted the multinational corporation exclusive, royalty-bearing licenses to Mendel's technology for use in large-acreage crops. Successful commercialization of products incorporating Mendel's technology, such as advanced soybean yield traits, results in milestone and royalty payments to the company. A strategic collaboration with BP, established in 2007, focused on developing and commercializing seeds for dedicated energy crops like Miscanthus and switchgrass for the second-generation biofuels industry. The company also engaged in research partnerships with Bayer CropScience to develop chemical products that regulate plant stress tolerance.
In December 2014, Mendel Biotechnology sold its research and development operations and certain assets to a subsidiary of Koch Agronomic Services. Following this transaction, Mendel Biotechnology transitioned to operate as an IP holding company, managing its extensive portfolio of patents and know-how related to genetic traits. The company continues to offer new licensing opportunities for its patented technologies. The R&D operations acquired by Koch were used to form a new business unit, initially called Koch Biological Solutions and later Mendel Biological Solutions, which was subsequently spun out and merged with another company in 2019.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 1997
- Headquarters
- Hayward, United States
- Open positions
- None listed
- Dealroom signal
- 50.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Dec 2014 | $0 | — | Koch Agronomic Services | — |
| SERIES F✓Equity / VC | Nov 2011 | $12M | $47M | Undisclosed | — |
Growth signals
Latest recorded traffic for Mendel Biotechnology is 230 monthly website visits, down 96.8% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Mendel Biotechnology in the Hayward ecosystem
The Mendel Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Capricorn Partners
Monsanto
Other known investors2 additional known investors
Koch Agronomic Services
University of California, Berkeley
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mendel Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mendel Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








